At first glance, feathers may seem like simple parts of a bird’s body. But if you look closer—under a microscope or through a ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

Using a computational strategy that allows them to combine information from many large datasets, MIT researchers have identified several new potential targets for Alzheimer’s disease.

Olutayo Farinde, a synthetic organic and medicinal chemist at the University of Toledo, has disclosed that fast-tracking organic methodology can accelerate a cure.

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

Shifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on ...

Driven by a commitment to achieve excellence since 1955, the Thomas J. Long School of Pharmacy trains pharmacists to excel as ...